Ocular Therapeutix Inc Cash Flow-to-Debt Ratio
Ocular Therapeutix Inc cash flow-to-debt ratio. Ocular Therapeutix Inc (OCUL) has a Cash Flow-to-Debt Ratio of -0.44x as of June 2026, meaning its operating cash flow of $-67.27 Million could theoretically repay 0% of its total liabilities ($151.28 Million) in one year. Check OCUL cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Ocular Therapeutix Inc (2012–2025)
Cash flow-to-debt ratio of Ocular Therapeutix Inc from 2012 to 2025. Historical debt coverage capacity for Ocular Therapeutix Inc across 14 annual periods. Also explore net asset momentum of Ocular Therapeutix Inc to track the company's year-over-year net asset growth rate.
Ocular Therapeutix Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Ocular Therapeutix Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Ocular Therapeutix Inc. For the full cash flow conversion analysis, see OCUL cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.33x | $-204.88 Million | $153.75 Million | ▼ -41.1% |
| 2024 | -0.94x | $-134.68 Million | $142.59 Million | ▼ -116.4% |
| 2023 | -0.44x | $-70.23 Million | $160.93 Million | ▲ +16.6% |
| 2022 | -0.52x | $-59.60 Million | $113.91 Million | ▲ +6.7% |
| 2021 | -0.56x | $-65.55 Million | $116.89 Million | ▼ -94.5% |
| 2020 | -0.29x | $-53.55 Million | $185.77 Million | ▲ +69.4% |
| 2019 | -0.94x | $-77.58 Million | $82.37 Million | ▲ +28.9% |
| 2018 | -1.32x | $-49.23 Million | $37.17 Million | ▲ +23.2% |
| 2017 | -1.72x | $-50.47 Million | $29.28 Million | ▼ -16.2% |
| 2016 | -1.48x | $-34.00 Million | $22.93 Million | ▲ +9.0% |
| 2015 | -1.63x | $-33.74 Million | $20.72 Million | ▼ -54.9% |
| 2014 | -1.05x | $-20.50 Million | $19.50 Million | ▼ -553.6% |
| 2013 | -0.16x | $-12.64 Million | $78.62 Million | ▲ +8.1% |
| 2012 | -0.18x | $-12.59 Million | $71.90 Million | — |